Sign In
Buy IMAB
$4.63
+0 (+0%)
At Close: Apr 14, 2026
Govt will not bailout airlines – Finance Minister
11:19am, Friday, 12'th Jun 2020
by BERNAMA / pic by BERNAMA
The government will not get involve in any bailout of airline operators although they are badly affected by the COVID-19 pandemic as their business is run commerciall
The government will not get involve in any bailout of airline operators although they are badly affected by the COVID-19 pandemic as their business is run commerciall
Malaysia will not bail out airlines, says Finance Minister
11:13am, Friday, 12'th Jun 2020
The Government will not get involved in any bailout of airline operators although they are badly affected by the COVID-19 pandemic as their business is run commercially, said Finance Minister Tengku D
Khazanah mulls RM5b aid for Malaysia Airlines
02:30am, Friday, 12'th Jun 2020
by BLOOMBERG/ pic by TMR FILE
KHAZANAH Nasional Bhd, Malaysia’s sovereign wealth fund, is considering providing as much as RM5 billion to the national flag carrier to see it through the coronavi
KHAZANAH Nasional Bhd, Malaysia’s sovereign wealth fund, is considering providing as much as RM5 billion to the national flag carrier to see it through the coronavi
Airlines stuck between capacity planning and making profits
02:03am, Friday, 12'th Jun 2020
Carriers would be able to stimulate the market by adding more capacity ahead of demand, but they risk flying empty planes
by RAHIMI YUNUS & SHAHEERA AZNAM SHAH/ graphic by MZUKRI LOCAL airlines ar
by RAHIMI YUNUS & SHAHEERA AZNAM SHAH/ graphic by MZUKRI LOCAL airlines ar
I-Mab Announces Upcoming Participation at June Conferences
12:00pm, Friday, 29'th May 2020
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat dise
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer
12:24pm, Thursday, 28'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) * ADC Therapeutics SA (NYSE: ADCT) (went public May 15
I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with -Cytokine Release Syndrome
08:05pm, Wednesday, 27'th May 2020
I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced interim results from a multi-center,
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme
12:00pm, Thursday, 21'st May 2020
I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with signif
I-Mab Expands Global Presence with New Hong Kong Office
08:00am, Wednesday, 20'th May 2020
I-Mab (NASDAQ:IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with signifi
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors
12:00pm, Wednesday, 13'th May 2020
I-Mab (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with signif
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
I-Mab Filed 2019 Annual Report on Form 20-F
01:24pm, Wednesday, 29'th Apr 2020
SHANGHAI, China and ROCKVILLE, MD., April 29, 2020 -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development.
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:40pm, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) * AstraZeneca plc (NYSE: AZN) * Alnylam Pharmaceuti
